Sun. 06 Apr 2025 🌧️ 6°C in Dublin
🎮 Games

Indian Stock Market Opens Lower on April 3 as U.S. Tariffs Rattle Investor Sentiment

Date: 03-apr-2025

Indian Stock Market Opens Lower on April 3 as U.S. Tariffs Rattle Investor Sentiment

The Indian stock market opened in the red on April 3, 2025, as fears over escalating trade tensions between the U.S. and India shook investor confidence. At 9:30 AM IST, both benchmark indices—the Nifty 50 and BSE Sensex—registered declines, triggered by the U.S. government’s move to impose a 26% reciprocal tariff on Indian goods.

Top 5 Indian Stock Indices

Nifty 50 ₹23,253.60 ▼ 0.34%
BSE Sensex ₹76,291.65 ▼ 0.43%
Nifty Bank ₹50,500.00 ▼ 0.65%
Nifty Midcap 100 ₹51,672.25 ▼ 0.32%
Nifty Smallcap 100 ₹16,095.70 ▼ 0.15%
Updated at: 9:30 AM IST, April 3, 2025

Top Gainers and Losers

Top 5 Gainers

Gland Pharma ₹2,500.00 ▲ 12.00%
Dr. Reddy's Laboratories ₹4,800.00 ▲ 6.00%
Cipla ₹1,100.00 ▲ 4.00%
Sun Pharmaceutical Industries ₹1,714.25 ▲ 4.00%
Lupin ₹900.00 ▲ 3.50%
Updated at: 9:30 AM IST, April 3, 2025

Top 5 Losers

Tata Motors ₹400.00 ▼ 3.00%
Hindalco Industries ₹450.00 ▼ 2.50%
JSW Steel ₹700.00 ▼ 2.00%
State Bank of India ₹500.00 ▼ 1.80%
Reliance Industries ₹2,300.00 ▼ 1.50%
Updated at: 9:30 AM IST, April 3, 2025

Index Performance at 9:30 AM

  • Nifty 50: Down by 0.56%, trading below the 23,200 mark.
  • S&P BSE Sensex: Dropped by 0.62%, falling to 76,140.58.

The losses reflect cautious trading as investors weigh the long-term implications of strained trade relations with the U.S., India's key export partner.

Pharma Stocks Buck the Trend

While the broader market saw weakness, pharmaceutical stocks defied the sell-off thanks to a key exemption in the U.S. tariff list. Indian pharma products will not be subject to the new tariffs, sparking a rally in the sector.

  • Gland Pharma: Soared over 12% in early trade.
  • Dr. Reddy’s Labs: Gained more than 6%.
  • Cipla & Sun Pharma: Each climbed around 4%.

Analysts believe the exemption signals U.S. dependence on Indian pharmaceutical exports, providing temporary relief to investors in the sector.

Market Outlook and Strategy

Experts suggest that volatility may persist throughout the day as more clarity emerges on India’s diplomatic response and global market cues. The rupee also opened weaker amid pressure from global risk aversion.

“Investors should adopt a wait-and-watch approach. While pharma remains a safe bet today, sectors exposed to U.S. exports like textiles and auto components could see further downside,” said Vishal Khurana, a senior market strategist at EquityWise.

What to Watch

  • India’s official statement or trade countermeasures, if any.
  • Updates from the U.S. on tariff implementation timelines.
  • Currency movement and FII flows throughout the session.

With the market reacting swiftly to global developments, investors are advised to stay informed and closely track both domestic and international headlines that could impact trading dynamics in the coming sessions.

Disclaimer: This article is based on publicly available information from various online sources. We do not claim absolute accuracy or completeness. Readers are advised to cross-check facts independently before forming conclusions.

🔄 Read More

📌 Latest Trending